The Middle East Prolactin Market was valued at US$ 28.6 million in 2024 and is projected to reach US$ 37.5 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period (2024–2030). This growth is being driven by expanding healthcare infrastructure, rising demand for reproductive health diagnostics, and increasing applications in oncology and metabolic research, with diagnostic uses accounting for 70% of market value and total consumption reaching approximately 12,000 grams in 2023.

As the healthcare sector in the Middle East advances toward precision medicine and enhanced endocrine care, the focus turns to the key players supplying prolactin for diagnostics, pharmaceuticals, and research. In this blog, we profile the Top 10 Companies in the Middle East Prolactin Market—a blend of regional pharmaceutical giants, diagnostic specialists, and biotech innovators shaping the future of hormone-related therapies and testing.

---

🔟 1. Rameda Pharmaceuticals

Headquarters: Cairo, Egypt (with strong Middle East distribution)
Key Offering: Human Prolactin diagnostic kits, recombinant prolactin for research

Rameda Pharmaceuticals stands out as a key supplier in the Middle East prolactin market, providing high-quality diagnostic assays and research-grade prolactin. Their products support fertility clinics and endocrine labs across the region, benefiting from a 12% surge in demand for high-sensitivity prolactin tests noted in 2023. The company focuses on affordable, reliable immunoassay platforms tailored for emerging healthcare needs.

Key Initiatives:

• Expansion of multiplex hormone panels including prolactin
• Partnerships with regional labs for automated testing systems
• Investments in local production to reduce import dependency

Download FREE Sample Report: Middle East Prolactin Market – View in Detailed Research Report

---

9️⃣ 2. CinnaGen Co.

Headquarters: Tehran, Iran
Key Offering: Recombinant human prolactin, prolactin ELISA kits

CinnaGen Co. plays a vital role in supplying biosimilars and diagnostic reagents in the Middle East, with prolactin products used in over 25% growth in primary care adoption in 2023. Their expertise in biotechnology enables production of cost-effective prolactin for pharmaceutical and research applications, serving hospitals and clinics amid rising endocrine disorder diagnoses.

Key Initiatives:

• Development of high-sensitivity assays for fertility testing
• Collaborations with Middle East research institutions

---

8️⃣ 3. Dar Al Dawa Development & Investment Co

Headquarters: Amman, Jordan
Key Offering: Prolactin-based therapeutics, diagnostic reagents

Dar Al Dawa is expanding its footprint in hormone diagnostics, capitalizing on the 30% increase in multiplex assay launches. Their prolactin offerings target pharmaceutical applications for hyperprolactinemia treatment and research into metabolic impacts, where studies rose 35% in recent years. This positions them strongly in Jordan and neighboring markets.

Key Initiatives:

• Targets for scalable production of animal and human prolactin
• Supply partnerships with Gulf clinics and hospitals

---

7️⃣ 4. SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation)

Headquarters: Riyadh, Saudi Arabia
Key Offering: Human prolactin standards, immunoassay kits

SPIMACO leads in Saudi Arabia’s prolactin supply, aligning with Vision 2030 healthcare goals. They provide prolactin for diagnostics dominating 70% of market value and support oncology research growing at 8% annually. Their state-backed facilities ensure reliable supply chains for the kingdom’s expanding labs.

Key Initiatives:

• Goal of 15% market share increase in diagnostic prolactin by 2030
• Launch of integrated testing systems in major hospitals

Download FREE Sample Report: Middle East Prolactin Market – View in Detailed Research Report

---

6️⃣ 5. Hikma Pharmaceuticals PLC

Headquarters: Amman, Jordan
Key Offering: Prolactin antagonists, diagnostic assays

Hikma Pharmaceuticals delivers prolactin-related products globally from its Middle East base, with a focus on injectable therapeutics and tests. They benefit from 20% YoY growth in automated immunoassay installations, serving UAE and Saudi markets where reproductive health focus intensifies.

Key Initiatives:

• Certified prolactin kits in key international labs
• Net-zero supply chain goals for biotech production

---

5️⃣ 6. Neopharma LLC

Headquarters: Abu Dhabi, UAE
Key Offering: Biosimilar prolactin, advanced diagnostic platforms

Neopharma is a frontrunner in UAE’s prolactin sector, supplying proprietary assays compatible with existing lab infrastructure. Their output supports fertility clinics seeing heightened demand, positioning them as a go-to for high-purity human prolactin in pharmaceutical and research uses.

Key Initiatives:

• Current diagnostic output exceeding regional needs
• Expansion to 50% capacity increase by 2026

---

4️⃣ 7. Tabuk Pharmaceutical Manufacturing Company

Headquarters: Tabuk, Saudi Arabia
Key Offering: Prolactin research reagents, pharma-grade hormones

Tabuk Pharma excels in local production for the Saudi market, crucial for logistics in Eastern Middle East. They contribute to R&D in synthetic prolactin under innovation programs, filling gaps in food industry and other niche applications.

Key Initiatives:

• Ongoing R&D for multiplex applications
• Local collaborations for scaled distribution

Download FREE Sample Report: Middle East Prolactin Market – View in Detailed Research Report

---

3️⃣ 8. Julphar (Gulf Pharmaceutical Industries)

Headquarters: Ras Al Khaimah, UAE
Key Offering: Human and animal prolactin variants

Julphar dominates UAE prolactin supply, distributing to over 50 airports and healthcare hubs metaphorically in diagnostics. They’ve advanced bio-prolactin testing, supporting civil and specialized endocrine care with successful regional validations.

Key Initiatives:

• Indigenous assay development programs
• Partnerships to boost production scale

---

2️⃣ 9. Abdi Ibrahim Pharmaceuticals

Headquarters: Istanbul, Turkey (extensive Middle East operations)
Key Offering: Prolactin therapeutics, diagnostic tools

Abdi Ibrahim is a powerhouse in regional refining and distribution of prolactin products. Their initiatives mirror large-scale expansions, converting facilities for biotech hormones to meet growing demands in metabolic research.

Key Initiatives:

• Production targets of enhanced reagent volumes by 2030
• Supply chain expansions across Gulf states

---

1️⃣ 10. Teva Pharmaceutical Industries Ltd.

Headquarters: Petah Tikva, Israel
Key Offering: Generic prolactin modulators, comprehensive diagnostic portfolios

Teva leads the Middle East prolactin market with end-to-end solutions, supporting thousands of labs, clinics, and research centers. As pioneers in generics, they drive accessibility in diagnostics and pharma, with strong focus on carbon-efficient production and offsets.

Key Initiatives:

• Comprehensive multiplex solutions for carriers
• Strategic alliances with producers and regulators

Read Full Report: Middle East Prolactin Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Middle East Prolactin Market Is Precise and Expansive

The Middle East prolactin market is evolving rapidly. While diagnostics hold the majority share, investments pour into pharmaceutical innovations, advanced assays, and research networks exploring links to oncology and metabolic disorders.

📈 Key Trends Shaping the Market:

• SAF capacity-like expansion in assay production across Saudi Arabia, UAE, and Qatar
• Regulatory mandates for integrated hormone testing by 2030
• Digitalization of lab workflows and result tracking
• Pharma-lab alliances for enhanced reproductive and endocrine care

Read Full Report: Middle East Prolactin Market – View in Detailed Research Report

The companies listed above are not only supplying critical prolactin solutions—they’re spearheading the precision health transition in the Middle East.